Suggested Modifications to the Pre-Arrest Morbidity (PAM) Index Original Modified Clinical Characteristic PAM Index PAM Index Malignancy 3 Metastatic - 10
Nonmetastatic - 3 Sepsis(*) 1 5 Dependent functional status 3 5 Pneumonia(*) 3 3 Creatinine > 130 [micro]mol/L(+) 3 3 Age > 70 y - 2 Acute myocardial infarction(*) 1 -2 Hypotension (systolic [is less than or equal to] 90 mm Hg) 3 - Heart failure (NYHA class III or IV) 1 - Angina pectoris 1 - S3 gallop 1 - Oliguria (<300 mL/d) 1 - Mechanical ventilation 1 - Recent cerebrovascular event 1 - Coma 1 - Cirrhosis 1 - Note: Patients with a score greater than 8 are unlikely to discharge following cardiopulmonary resuscitation.
Low-risk MB includes the WNT subgroup and
nonmetastatic group 4 tumors with chromosome 11 loss or 17 gain.
Okafor, M.D., M.P.H., from Stanford University in California, and colleagues used the Surveillance, Epidemiology, and End Results-Medicare database to identify 3,408 patients with
nonmetastatic RC between 2005 and 2007.
To the Editor: A 64-year-old Chinese man had a 12-month history of
nonmetastatic primary scalp angiosarcoma [Figure 1]a that had been confirmed by skin biopsy [Figure 1]e.
With surgical and histological findings as reference, the location of gastric cancer lesions, the status of metastatic and
nonmetastatic LNs, and CT enhancement from iodine map were evaluated.
The purpose of this study is to examine the impact of locoregional therapy, particularly the extent of surgical therapy, on survival in a large population cohort of women with
nonmetastatic IBC.
They were classified into two groups: 24 cases of
nonmetastatic breast cancer and 26 cases of metastatic breast cancer.
Combination chemotherapy given both pre- and postoperatively has raised the overall survival of patients with primary
nonmetastatic osteosarcoma from 20 to 65% [1-3].
The medical records of 189 consecutive
nonmetastatic esophageal carcinoma patients treated in the Sun Yat-sen Memorial Hospital, Sun Yat-sen University, between January 2012 and December 2013, were reviewed.
The IsoPic system is intended to, from a blood sample, identify, concentrate, and purify CTC to make them available as a sample to support the enumeration and analyses to support diagnosis of metastatic tumors and those
nonmetastatic tumors that may release circulating tumor cells.
[28] showed that a 10-year survival rate among patients with
nonmetastatic melanoma with vitiligo was 49%.
Unfortunately, prognosis is poor, with a 5-year survival rate of about 35% in
nonmetastatic angiosarcoma cases.